Discover trends, market shifts, and competitive outlooks for the drug discovery outsourcing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Drug Discovery Outsourcing Market, and What Factors Will Drive It?

The market size for outsourcing in drug discovery has seen significant expansion in the past few years. It is projected to rise from $3.92 billion in 2024 to $4.24 billion in 2025, marking a compound annual growth rate (CAGR) of 8.1%. The historic growth can be credited to the increasing complexity of drug discovery, the essential need for specialized knowledge, strict regulatory norms, the worldwide spread of clinical trials, and an increase in demand for orphan drugs and personalized medicine.

The market size for outsourcing in drug discovery is anticipated to experience significant expansion in the upcoming years, potentially reaching a value of $5.72 billion in 2029 with a compound annual growth rate of 7.8%. This projected growth during the forecast period can be related to the increasing costs in research and development, the expiry of patents, the development of the biopharmaceutical sector, a focus on key skills and the need to decrease market-entry time. Key trends predicted for the forecast period are the increased use of artificial intelligence, technological progress, the utilization of big data analytics, the prominence of specialty drugs, and the emphasis on collaboration and strategic partnerships.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19405&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Drug Discovery Outsourcing Market?

The emergence of chronic diseases on an increasing scale is anticipated to propel the expansion of the drug discovery outsourcing market in the future. Chronic illnesses, often lasting several years or even a lifetime, are health conditions that continue over a certain period of time. An aging population, lifestyle choices, urbanization, and environmental elements are some of the reasons behind the escalating instances of chronic diseases. The drug discovery outsourcing process hastens the creation of treatments for chronic illnesses by offering access to specific expertise and innovative technologies, thus lessening the timeframe and expenses involved. As evidence, a report by the Australian Institute of Health and Welfare, a government agency in Australia, in June 2024 stated that 61% of the populace, equivalent to roughly 15.4 million people, were suffering from at least one long-term health disorder, accounting for 90% of deaths in 2022. Anxiety plagued 1.3 million individuals (16%) in the 0-24 age group and 1.6 million individuals (22%) in the 25-44 age bracket. Back problems were common among 1.5 million people (23%) aged 45-64, while deafness or hearing loss was the plight of 1.3 million persons (32%) from the 65 and above age group. Hence, the escalating rate of chronic illnesses is fueling the growth of the drug discovery outsourcing market.

Which Key Market Segments Comprise the Drug Discovery Outsourcing Market and Drive Its Revenue Growth?

The drug discovery outsourcingmarket covered in this report is segmented –

1) By Service Type: Chemistry Services, Biological Services

2) By Workflow: Target Identification And Screening, Target Validation And Functional Informatics, Lead Identification And Candidate Optimization, Preclinical Development, Other Workflows

3) By Disease Model: In Vitro Models, Animal Models, Cellular Models, Other Disease Models

4) By Therapeutic Area: Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Hematology, Respiratory System, Infectious Disease, Oncology, Immunology, Other Therapeutic Areas

5) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users

Subsegments:

1) By Chemistry Services: Custom Synthesis And Manufacturing, Medicinal Chemistry, Combinatorial Chemistry, Hit Identification And Lead Optimization, Process Chemistry And Scale-Up, Analytical Chemistry Services, Chemical Library Design And Screening, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling

2) By Biological Services: Cell-Based Assays And Screening, Target Identification And Validation, In Vitro And In Vivo Testing, Biomarker Discovery And Development, Toxicology Studies, Genomics And Proteomics Services, Animal Models For Preclinical Development, Biological Safety And Efficacy Testing, Biopharmaceutical Development And Manufacturing.

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19405&type=smp

Which Areas Are Leading Regions in the Drug Discovery Outsourcing Market Expansion Across the Globe?

North America was the largest region in the drug discovery outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Drug Discovery Outsourcing Market?

Leading firms in the drug discovery outsourcing market are emphasizing the creation of innovating solutions such as digital health systems. These systems are designed to provide more effective services to healthcare professionals, regulatory bodies, and patients. Digital health solutions comprise technologies and services like telemedicine, mobile health applications, and wearable devices. All these aim to improve healthcare delivery, patient interactions, and management of health. For instance, in November 2023, AstraZeneca PLC, a biopharmaceutical company from the UK, introduced Evinova. Evinova is a pioneering health-tech business dedicated to promoting innovation in the life sciences field and improving the execution of clinical trials. Its goal is to enhance health outcomes by providing digital services and products already successfully implemented in AstraZeneca’s clinical trials in over 40 different nations globally. Evinova aims for the optimization of clinical trial design and delivery, to make the drug development processes more efficient, ultimately saving time and costs.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-outsourcing-global-market-report

How Is the Drug Discovery Outsourcing Market Conceptually Defined?

Drug discovery outsourcing refers to the practice of pharmaceutical companies contracting external organizations to conduct various stages of the drug discovery process, such as target identification, lead optimization, and preclinical testing, to leverage specialized expertise, reduce costs, and accelerate development timelines.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19405

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model